SK Biopharmaceuticals Co., Ltd. (KRX:326030)
88,400
-700 (-0.79%)
At close: Jun 2, 2026
-4.95% (1Y)
| Market Cap | 6.92T -10.7% |
| Revenue (ttm) | 790.25B +36.7% |
| Net Income | 348.81B +38.9% |
| EPS | 4,452.58 +38.8% |
| Shares Out | 78.31M |
| PE Ratio | 19.85 |
| Forward PE | 21.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 282,903 |
| Open | 87,700 |
| Previous Close | 89,100 |
| Day's Range | 87,300 - 89,900 |
| 52-Week Range | 87,300 - 144,100 |
| Beta | 0.79 |
| Analysts | Buy |
| Price Target | 137,923.08 (+56.02%) |
| Earnings Date | May 7, 2026 |